-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FOZsgLP0tUkIsE9yETho3ngP6yHNXkvbVrmJeIT65q2LXdVB3P+CJQG6DAACZmSz JiGUUJ9ouoZI8X3JvIhmQA== 0001069702-05-000003.txt : 20050308 0001069702-05-000003.hdr.sgml : 20050308 20050308215602 ACCESSION NUMBER: 0001069702-05-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050303 FILED AS OF DATE: 20050308 DATE AS OF CHANGE: 20050308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOTECHNOLOGY CORP CENTRAL INDEX KEY: 0000789097 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 841016435 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 1661 LAKEVIEW CIRCLE CITY: OGDEN STATE: UT ZIP: 84403 BUSINESS PHONE: 8013993632 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTECHNOLOGY LABORATORIES INC DATE OF NAME CHANGE: 19900503 FORMER COMPANY: FORMER CONFORMED NAME: LJC CORP DATE OF NAME CHANGE: 19891025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHARMANN MARK A CENTRAL INDEX KEY: 0001031893 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24641 FILM NUMBER: 05668026 BUSINESS ADDRESS: BUSINESS PHONE: 8013993632 MAIL ADDRESS: STREET 1: 1661 LAKEVIEW CIRCLE STREET 2: 1661 LAKEVIEW CIRCLE CITY: OGDEN STATE: UT ZIP: 84403 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2005-03-03 0 0000789097 IMMUNOTECHNOLOGY CORP IMNT 0001031893 SCHARMANN MARK A 1 1 1 0 President Common Stock 2005-03-03 4 D 0 250000 0.0388 D 27473760 D Common Stock 337500 I Reporting Person's IRA Common Stock 7250 I Shares held by Troika Capital, Inc., an entity controlled by the Reporting Person Mark A. Scharmann 2005-03-08 -----END PRIVACY-ENHANCED MESSAGE-----